Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 7 member 5 pseudogene 1 (SLC7A5P1) is a **pseudogene** of the L-type amino acid transporter 1 (LAT1, SLC7A5)[3][1]. Unlike functional members of the SLC7 family, SLC7A5P1 does not encode a protein with confirmed biological transporter activity[3]. It is classified as a non-coding genomic locus, and there is no evidence that it produces a functional protein or has a role as a drug target or biomarker. The locus may produce transcripts, but these do not translate into active transporter proteins or serve recognized biological functions[3][1]. Therefore, SLC7A5P1 is not considered a therapeutic target, nor does it have disease associations or known safety concerns typically attributed to active molecular targets. **Note:** The functional L-type amino acid transporter 1 (LAT1, SLC7A5), a different gene, is an important transporter involved in cancer and central nervous system drug delivery, but SLC7A5P1 itself is specifically a pseudogene and not a molecular target[3][1][4][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 7 member 5 pseudogene 1 (SLC7A5P1).